Ustekinumab

tried an IL-12 or IL-23 blocker, and this patient went into remission in like overnight, okay? Overnight.

And these are, you know, Stelara is what blocks IL-12 and 23, and there's several molecules that block only IL-23.

And what was very, very interesting is we had initially this one patient that had these findings that responded so dramatically to IL-1223.

And we then studied that patient as well as the other six patients that had the same phenotype.